Device
TAP20-C
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
0(0%)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Terminated(2)
Other(1)
Detailed Status
Withdrawn2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
withdrawn267%
unknown133%
Recent Activity
0 active trials
Showing 3 of 3
withdrawnnot_applicable
A Study to Compare Analytes in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
NCT01786408
withdrawnnot_applicable
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
NCT01934842
unknownnot_applicable
A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick
NCT02045758
Clinical Trials (3)
Showing 3 of 3 trials
NCT01786408Not Applicable
A Study to Compare Analytes in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
NCT01934842Not Applicable
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
NCT02045758Not Applicable
A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3